首页> 外文OA文献 >Efficacy and Safety of Timolol-Dorzolamide Fixed-Combination Three Times a Day Versus Two Times a Day in Newly Diagnosed Open Angle Glaucoma

【2h】

Efficacy and Safety of Timolol-Dorzolamide Fixed-Combination Three Times a Day Versus Two Times a Day in Newly Diagnosed Open Angle Glaucoma

机译：蒂洛尔 - 多尔胺固定组合的疗效和安全性每天三次与新诊断的开角型青光眼每天两次相比

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mohammad Pakravan; Afsaneh Naderi Beni; Shahin Yazdani; Hamed Esfandiari;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Elderly multiple myeloma (MM) patients, who are generally ineligible for transplantation, have high risks of death and treatment discontinuation, and require a regimen incorporating novel agents that balance safety, tolerability, and efficacy. We evaluated alternating bortezomib-dexamethasone and lenalidomide-dexamethasone treatments administered over a 63-day cycle in transplant-ineligible elderly patients with newly diagnosed MM. Subcutaneous bortezomib 1.3 mg/m2 was administered weekly on Days 1, 8, 15, and 22; oral lenalidomide 15 mg daily on Days 36-56; and oral dexamethasone 20 mg on Days 1, 8, 15, 22, 36, 43, 50, and 57 for 6 cycles. The primary endpoint was the overall response rate. [J] . Yokoyama Akihiro, Kada Akiko, Saito Akiko M., Acta medica Okayama . 2019,第6期

机译：通常不适合移植的老年多发性骨髓瘤（MM）患者具有很高的死亡和中止治疗的风险，因此需要一种方案，该方案应采用能够平衡安全性，耐受性和疗效的新型药物。我们评估了在不适合移植的老年初诊MM患者中，硼替佐米-地塞米松和来那度胺-地塞米松在63天周期内的交替治疗。在第1、8、15和22天每周一次皮下注射硼替佐米1.3 mg / m2;在第36-56天每天口服来那度胺15 mg;在第1、8、15、22、36、43、50和57天，口服地塞米松20 mg，共6个周期。主要终点是总体缓解率。
2. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis. [J] . Chervinsky P, Nayak A, Rooklin A, Allergy and asthma proceedings . 2005,第5期

机译：每天两次两次服用地氯雷他定/伪麻黄碱片2.5 / 120 mg的疗效和安全性，与治疗季节性变应性鼻炎患者的单个成分相比。
3. Efficacy and Cardiovascular Safety of Topical Timolol, Brimonidine & Latanoprost in Newly Diagnosed Patients of Open Angle Glaucoma [J] . Kiran Kapoor, Vijay Khajuria, B. Kapoor, JK Science : Journal of Medical Education & Research . 2013,第1期

机译：局部用替莫洛尔，溴莫尼定和拉坦前列素在新诊断的开角型青光眼患者中的疗效和心血管安全性
4. Effect of Adjuvant on the Efficacy of Glyphosate Applied at Different Times of Day [C] . Bryan G. Young, Julie M. Young, American Society for Testing and Materials(ASTM)(US), Symposium on Pesticide Formulations and Delivery Systems: The Continued Evolution of Agrochemicals . 2005

机译：佐剂对不同时间在不同时间应用的草甘膦疗效的影响
5. Application and Viability of Long Day Lighting on a Large Michigan Dairy Farm Milking Three Times Each Day [D] . VanZweden, Benjamin 2019

机译：密歇根州大型奶牛场每天挤奶三天，长时间照明的应用和可行性
6. Protocol: Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre prospective randomised controlled open-label non-inferiority study [O] . Zexuan Wu, Dexi Wu, Jingzhou Jiang, 2020

机译：方案：血脂康在轻度至中度高胆固醇血症患者中的疗效和安全性每天一次每天两次； APEX研究：一项多中心前瞻性随机对照开放标签非自卑性研究的方案
7. Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study [O] . Zexuan Wu, Dexi Wu, Jingzhou Jiang, 2020

机译：徐志康每天一次与每天两次患者每天对患者的两次（APEX研究）（APEX研究）：多期，前瞻性随机控制，开放式标签，非劣级研究的议定书

Efficacy and Safety of Timolol-Dorzolamide Fixed-Combination Three Times a Day Versus Two Times a Day in Newly Diagnosed Open Angle Glaucoma

著录项

相似文献

相关主题

期刊订阅